3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
14
Sarcoma
9
Lymphoid
6
Gastrointestinal
4
Other hematologic neoplasm
3
Plasma cell
1
Head & Neck
1
Dermatologic
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
638
Head and Neck Neoplasms
609
Carcinoma, Non-Small-Cell Lung
202
Thyroid Neoplasms
200
Melanoma
145
Nasopharyngeal Carcinoma
136
Oropharyngeal Neoplasms
129
Colorectal Neoplasms
129
Mouth Neoplasms
128
Neoplasms
113
Breast Neoplasms
112
Ovarian Neoplasms
105
Lung Neoplasms
105
Uterine Cervical Neoplasms
101
Neoplasm Metastasis
93
Carcinoma, Squamous Cell
86
Stomach Neoplasms
84
Carcinoma, Renal Cell
84
Triple Negative Breast Neoplasms
79
Pancreatic Neoplasms
72
Esophageal Neoplasms
70
Laryngeal Neoplasms
67
Endometrial Neoplasms
67
Urinary Bladder Neoplasms
61
Sarcoma
58
Prostatic Neoplasms
55
Thyroid Cancer, Papillary
54
Salivary Gland Neoplasms
49
Carcinoma, Transitional Cell
47
Carcinoma, Hepatocellular
46
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Head & Neck
×
1 year
×
Clear all
NCT04141449
2025-12-31
Potlako+
Brigham and Women's Hospital
Phase 2
Active not recruiting
874 enrolled